Objectives Fatigue is a pervasive clinical symptom in coronaviruses and may continue
beyond the acute phase, lasting for several months or years. This systematic review and …

Background The prevalence and prognosis of post-acute stage SARS-CoV-2 infection
fatigue symptoms remain largely unknown. Aims We performed a systematic review to …

Background Severe fatigue can persist for months after coronavirus disease 2019 (COVID-
19) onset. This longitudinal study describes fatigue severity and its determinants up to 12 …

Fatigue is a common symptom in those presenting with symptomatic COVID-19 infection.
However, it is unknown if COVID-19 results in persistent fatigue in those recovered from …

Objectives Fatigue syndromes have been widely observed following post-viral infection and
are being recognised because of Covid19. Interventions used to treat and manage fatigue …

The post-COVID-19 syndrome may affect patients after the COVID-19 post-acute phase. In
particular, the 69% of patients reported persistent fatigue at the discharge. To date, no clear …

Background Fatigue is the most prevalent and debilitating long-COVID (coronavirus
disease) symptom; however, risk factors and pathophysiology of this condition remain …

Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019
(COVID-19)(sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue …

Background Fatigue is a common symptom in hospitalized and non-hospitalized patients
recovering from COVID-19, but no fatigue measurement scales or questions have been …

Fatigue is recognized as one of the most commonly presented long-term complaints in
individuals previously infected with SARS-CoV-2. This systematic review was performed to …